Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis

Genes Immun. 2003 Jun;4(4):258-64. doi: 10.1038/sj.gene.6363959.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic disorder of the lung parenchyma. We have demonstrated changes in IL-10 protein production by alveolar macrophages (AMs) from patients with IPF, which we hypothesise could be because of an IL-10 gene polymorphism. We have screened the coding sequence and 3' untranslated region of IL-10 for polymorphisms using single-standard conformational polymorphism analysis. A novel polymorphism was identified resulting in a G to A substitution of +43 nucleotides from the start codon changing glycine to arginine at amino acid 15 of the signal peptide sequence. We have introduced the signal peptide mutation into the IL-10 gene and compared secretion of the mutant and wild-type forms after transient transfection of COS-7 cells. Our studies showed that the signal peptide mutation did not have a significant effect on secretion at 24 h post-transfection (P=0.4529 by Mann-Whitney test). However, by 48 h there are significantly lower levels of mutant IL-10 (P=0.0515). There were no differences in the level of cell-associated IL-10 at either 24 or 48 h (P=0.9296 and 0.4268). We suggest that the mutation could affect the efficiency of protein translocation and signal peptide cleavage resulting in lower levels of IL-10 protein secretion.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • COS Cells
  • Chlorocebus aethiops
  • Female
  • Humans
  • Interleukin-10 / genetics*
  • Interleukin-10 / metabolism
  • Male
  • Middle Aged
  • Mutation
  • Polymorphism, Single-Stranded Conformational*
  • Pulmonary Fibrosis / genetics*
  • Pulmonary Fibrosis / immunology*

Substances

  • Interleukin-10